Top Stories S&P says downgrade risk exists, leaves rating unchanged The global rating agency Standard & Poor's (S&P) affirmed BBB- rating for India... ...
http://www.indiainfoline.com/Markets/News/India-Infoline-Weekly-Newsletter-May-17-2013/5685274749Cadila Healthcare has declared the first day launch of Zolmitriptan orally disintegrating tablets upon receiving the final approval from the US... ...
http://www.indian-commodity.com/corporate/cadila-healthcare-launches-zolmitriptan-in-us-market.aspxGlenmark Pharmaceuticals lost 2.13% to Rs 565 at 10:06 IST on BSE, with the stock sliding after recent rally triggered by the firm's step down... ...
http://www.indiainfoline.com/Markets/News/Glenmark-Pharma-drops-after-3-day-8.2-percent-rally/4869770752EBIDTA for the quarter has grown to Rs 38.16 crore up by 63%, as against Rs 23.5 crore in the same period of the last year. Arvind Remedies Ltd... ...
http://www.indiainfoline.com/Markets/News/Arvind-Remedies-Q4-net-profit-at-Rs124.1mn/5683898220Posted by Equitymaster Backed by consistent selling activity Indian equity markets have slipped down during the post noon trading session. The... ...
http://feeds.equitymaster.com/~r/TodaysMarket/~3/vCwvqQz-cgw/tm.asp